Italia markets closed

iRhythm Technologies, Inc. (0A7L.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
151,09+7,37 (+5,13%)
Alla chiusura: 02:30PM BST
Schermo intero
Chiusura precedente143,72
Aperto151,09
Denaro0,00 x N/D
Lettera0,00 x N/D
Min-Max giorno151,09 - 151,09
Intervallo di 52 settimane151,09 - 151,09
Volume10
Media VolumeN/D
CapitalizzazioneN/D
Beta (5 anni mensile)1,50
Rapporto PE (ttm)N/D
EPS (ttm)-4,22
Prossima data utili02 nov 2022 - 07 nov 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    iRhythm Technologies Announces Second Quarter 2022 Financial Results

    SAN FRANCISCO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended June 30, 2022. Second Quarter 2022 Financial Highlights Revenue of $102.1 million, a 25.6% increase compared to second quarter 2021Gross margin of 68.8%, a 0.8 percentage point improvement compared to second quarter 2021Cash and short-term investments of $2

  • GlobeNewswire

    iRhythm Technologies to Present at the Canaccord Genuity 42nd Annual Growth Conference

    SAN FRANCISCO, July 28, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming Canaccord Genuity 42nd Annual Growth Stock Conference. iRhythm’s management is scheduled to present on Thursday, August 11, 2022, at 12:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investor

  • GlobeNewswire

    iRhythm Technologies Announces the Addition of Two Executive Leaders to Advance Strategic Growth and Operational Excellence

    SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the appointment of two seasoned executives to its leadership team. Brice Bobzien will join the company as the Chief Financial Officer on August 8, 2022, to lead all financial operations of the company as well as to advance the culture of operational excellence and prepare the company for future growth